Systemic safety ofbevacizumab versusranibizumab forneovascularage-related maculardegeneration Lorenzo MojaErsilia LucenteforteKoren Hyogene Kwag2014 год

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
reference-entry